Dropain P 80mg/500mg Tablet belongs to the class of medicine called 'antispasmodic' combined with a painkiller, used to reduce and relieve abdominal pain and muscle spasms in the gastrointestinal tract, urinary tract and gall bladder. Abdominal (tummy) pain occurs between your chest and pelvic region (below the belly button and leg). 

Dropain P 80mg/500mg Tablet is a combination of two drugs: Drotaverine (antispasmodic) and Paracetamol (pain killer). Drotaverine works by relieving contractions (spasms) associated with smooth muscles of the abdomen. Paracetamol is an analgesic (pain reliever) and an antipyretic (fever reducer). It inhibits cyclo-oxygenase (COX) enzymes that further prevent the formation of chemical messengers called 'prostaglandins' (PGs). These prostaglandins are produced at injury sites and cause pain and swelling. By blocking COX enzyme's effect, lesser PGs are produced, which reduces mild to moderate pain and inflammation at the injured or damaged site. Together, Dropain P 80mg/500mg Tablet helps in relieving abdominal pain and cramps.

Your doctor will decide the dose and duration based on the severity of your pain. Common side effects of Dropain P 80mg/500mg Tablet include dry mouth, feeling thirsty, and dizziness. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you use any prescription and non-prescription medications, including other vitamins, before starting Dropain P 80mg/500mg Tablet. Inform your doctor if you have any liver, heart or kidney diseases and alcohol dependency before taking Dropain P 80mg/500mg Tablet. Consult your doctor if you are pregnant, planning for pregnancy or breastfeeding before taking Dropain P 80mg/500mg Tablet. Dropain P 80mg/500mg Tablet may cause dizziness, so drive only if you are alert. Avoid consuming alcohol along with Dropain P 80mg/500mg Tablet as it could lead to increased dizziness and risk of liver damage. Dropain P 80mg/500mg Tablet should not be given to children below one year of age as safety has not been established.

Dropain P 80mg/500mg Tablet consists of Drotaverine (antispasmodic) and Paracetamol (pain killer). It relieves abdominal pain, and muscle spasms in the gastrointestinal tract, urinary tract and gall bladder. Drotaverine works by reducing contractions (spasms) associated with smooth muscles of the abdomen. Paracetamol is an analgesic (pain reliever) and an antipyretic (fever reducer). It inhibits cyclo-oxygenase (COX) enzymes that further prevents the formation of chemical messengers called 'prostaglandins' (PGs). These prostaglandins are produced at injury sites and cause pain and swelling. By blocking COX enzyme's effect, lesser PGs are produced, which reduces mild to moderate pain and inflammation at the injured or damaged site. Together, Dropain P 80mg/500mg Tablet helps in relieving abdominal pain and cramps.

Let your doctor know if you use any prescription and non-prescription medications, including other vitamins, before starting Dropain P 80mg/500mg Tablet. Inform your doctor if you have any liver, heart or kidney diseases and alcohol dependency. Dropain P 80mg/500mg Tablet may cause fluid retention (oedema); hence it is advised to monitor blood pressure and cardiovascular status in patients with a heart failure history. Do not take Dropain P 80mg/500mg Tablet if you are breastfeeding. Please consult your doctor know if you are pregnant and planning to conceive. Avoid consuming alcohol along with Dropain P 80mg/500mg Tablet as it could lead to increased dizziness and risk of liver damage. Dropain P 80mg/500mg Tablet is not recommended in children below one year of age.

• Let your doctor know that you are taking Dropain P 80mg/500mg Tablet if you are undergoing any medical tests.
• Monitor your blood pressure regularly since Drotaverine in Dropain P 80mg/500mg Tablet may lower your blood pressure.
• Dropain P 80mg/500mg Tablet may cause fluid retention (oedema); hence it is advised to monitor blood pressure and cardiovascular status in patients with a heart failure history.